Mechanism of blood-activating and mass-dissipating Chinese patent medicine against hyperplasia of mammary glands and use with other medicine: a review.
10.19540/j.cnki.cjcmm.20220928.601
- Author:
Qi-Rui FAN
1
;
Mei CHEN
1
;
Xiao-Yi DONG
1
;
Rui TAO
1
;
Jing-Rui WANG
1
;
Shun-Li XIA
1
;
Tao HAN
2
Author Information
1. Gansu University of Chinese Medicine Lanzhou 730000, China.
2. Gansu University of Chinese Medicine Lanzhou 730000, China Key Laboratory of Pharmacology and Toxicology of TCM of Gansu Province Lanzhou 730000, China.
- Publication Type:Journal Article
- Keywords:
Chinese patent medicine;
blood-activating and mass-dissipating;
hyperplasia of mammary glands;
mechanism;
use of medicine in combination
- MeSH:
Humans;
Female;
Hyperplasia/drug therapy*;
Nonprescription Drugs;
Mammary Glands, Human/pathology*;
Medicine, Chinese Traditional;
Hemorheology;
Drugs, Chinese Herbal/therapeutic use*
- From:
China Journal of Chinese Materia Medica
2023;48(2):292-299
- CountryChina
- Language:Chinese
-
Abstract:
Caused by endocrine disorder, hyperplasia of mammary glands(HMG) tends to occur in the young with increasing incidence, putting patients at the risk of cancer and threatening the health of women. Therefore, the prevention and treatment of HMG is attracting more and more attention. Amid the modernization of traditional Chinese medicine(TCM), many scholars have found that Chinese patent medicine has unique advantages and huge potential in treatment of endocrine disorder. Particularly, Chinese patent medicine with the function of blood-activating and mass-dissipating, such as Xiaojin Pills and Xiaozheng Pills, has been commonly used in clinical treatment of HMG, which features multiple targets, obvious efficacy, small side effect, and ease of taking and carrying around. Clinical studies have found that the combination of Chinese patent medicine with other medicine can not only improve the efficacy and relieve symptoms such as hyperplasia and pain but also reduce the toxic and side effects of western medicine. Therefore, based on precious pharmacological research and clinical research, this study reviewed the mechanisms of blood-activating mass-dissipating Chinese patent medicine alone and in combination with other medicine, such as regulating levels of in vivo hormones and receptors, promoting apoptosis, inhibiting angiogenesis, improving hemorheology indexes, enhancing immunity, and boosting antioxidant ability. In addition, limitations and problems were summarized. Thereby, this study is expected to lay a theoretical basis for the further study and clinical application of blood-activating mass-dissipating Chinese patent medicine alone or in combination with other medicine against HMG.
